Ravulizumab (ALXN1210)

ravulizumab · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ravulizumab (ALXN1210), covering 2019-03-21 to 2019-03-21. Get the full timeline:

Most recent: Clinical Trial Update: ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab [Phase 3]

See pricing